|
|
| Word Search |
3SBio Inc. Announces Unaudited Second Quarter Results
3SBio
(August 18, 2010)
|
Rockwell Medical Appoints Dr. Iain Macdougall to Scientific Advisory Board
Rockwell Medical Technologies
(August 16, 2010)
|
Affymax and Takeda Announce Preliminary U.S. Registration Strategy for Investigational Drug, Hematide(™)
Takeda
(August 05, 2010)
|
Affymax and Takeda Announce Preliminary U.S. Registration Strategy for Investigational Drug, Hematide(TM)/Peginesatide, To Treat Anemia In Chronic Renal Failure
Affymax
(August 05, 2010)
|
XTL Completes Acquisition of Bio-Gal
XTL Biopharmaceuticals
(August 04, 2010)
|
HemoBioTech Announces New Patent for Treating Acute Blood Loss
HemoBioTech
(July 28, 2010)
|
Medicare dialysis rules to re-shape ESA market
(July 28, 2010)
|
Hospira Begins Phase I U.S. Clinical Trial of Biosimilar Erythropoietin in Renal Patients
Hospira
(July 26, 2010)
|
Akebia Announces Initiation of Phase 2a Clinical Study of AKB-6548
Akebia Therapeutics
(July 22, 2010)
|
FY2010 2Q Consolidated Financial Overview
Chugai
(July 22, 2010)
|
|
|
|
|
|
|
|